Return
Biography
Byron

Dr. Byron E. E. Martina

Erasmus MC

Netherlands


Email: b.martina@erasmusmc.nl


Qualifications

2003 Ph.D., Virology, Erasmus MC, The Netherlands

1999 M.Sc., Infection and Immunity, De Montfort University, United Kingdom

1994 B.Sc., Medical Microbiology, Poly Technical Faculty


Publications (selected)

  1. W. Schaftenaar, D.V.M., C. Reid, Ph.D., D.V.M., B. Martina, Ph.D., J. Fickel, Ph.D., and A. D. M. E. Osterhaus, Ph.D.Nonfatal clinical presentation of elephant endotheliotropic herpes virus discovered in a group of captive asian elephants (elephas maximus). Journal of Zoo and Wildlife Medicine 2010; 41(4): 626–632.
  2. Martina Byron E E; Koraka Penelope; Osterhaus Albert D M E.West Nile Virus: is a vaccine needed?Current opinion in investigational drugs (London, England : 2000) 2010;11(2):139-46.
  3. Spohn Gunther; Jennings Gary T; Martina Byron Ee; Keller Iris; Beck Markus; Pumpens Paul; Osterhaus Albert DME; Bachmann Martin F.A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.Virology 2010;7():146.
  4. Koraka Penelope; Martina Byron E E; Osterhaus Albert D M E.Bioinformatics in new generation flavivirus vaccines.Journal of biomedicine & biotechnology 2010;2010():864029.
  5. Koraka Penelope; Lim Yow-Pin; Shin Michael D; Setiati Tatty E; Mairuhu Albert T A; van Gorp Eric C M; Soemantri Augustinus; Osterhaus Albert D M E; Martina Byron E E.Plasma levels of inter-alpha inhibitor proteins in children with acute Dengue virus infection.PloS one 2010;5(4):e9967.
  6. Bomers MK, Lettinga KD, van Gorp EC, Martina BE, Peerbooms PG, Veenstra J.Dengue infection with fatal ending. Ned Tijdschr Geneeskd. 2009;153:A725.
  7. Martina Byron E E; Koraka Penelope; Osterhaus Albert D M E.Dengue virus pathogenesis: an integrated view.Clinical microbiology reviews 2009;22(4):564-81.
  8. Koraka Penelope; Williams Marisol M; Djamiatun Kis; Setiati Tatty E; van Batenburg F H D; Stittelaar Koert J; Osterhaus Albert D M E; Martina Byron E E.RNA secondary structures in the proximal 3'UTR of Indonesian Dengue 1 virus strains.Virus research 2009;142(1-2):213-6.
  9. Martina Byron E E; Osterhaus Albert D M E."Filoviruses": a real pandemic threat?EMBO molecular medicine 2009;1(1):10-8.2009: Huisman W; Martina B E E; Rimmelzwaan G F; Gruters R A; Osterhaus A D M E.Vaccine-induced enhancement of viral infections.Vaccine 2009;27(4):505-12.
  10. Bomers Marije K; Lettinga Kamilla D; van Gorp Eric C M; Martina Byron E E; Peerbooms Paul G H; Veenstra Jan.[Dengue infection with fatal ending]. Nederlands tijdschrift voor geneeskunde 2009;153():A725.
  11. van den Brand J M A; Haagmans B L; Leijten L; van Riel D; Martina B E E; Osterhaus A D M E; Kuiken T.Pathology of experimental SARS coronavirus infection in cats and ferrets.Veterinary pathology 2008;45(4):551-62.
  12. Rijks J M; Read F L; van de Bildt M W G; van Bolhuis H G; Martina B E E; Wagenaar J A; van der Meulen K; Osterhaus A D M E; Kuiken T.Quantitative analysis of the 2002 phocine distemper epidemic in the Netherlands.Veterinary pathology 2008;45(4):516-30.
  13. Martina Byron E E; Koraka Penelopie; van den Doel Petra; Rimmelzwaan Guus F; Haagmans Bart L; Osterhaus Albert D M E.DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.Virus research 2008;135(1):64-71.
  14. Martina Byron E; Koraka Penelopie; van den Doel Petra; van Amerongen Geert; Rimmelzwaan Guus F; Osterhaus Albert D M E.Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.Vaccine 2008;26(2):153-7.
  15. van Elk C E; van Dep Bildt M W G; Martina B E E; Osterhaus A D M E; Kuiken TEscherichia coli septicemia associated with lack of maternally acquired immunity in a bottlenose dolphin calf.Veterinary pathology 2007;44(1):88-92.
  16. Martina Byron E; Verjans Georges M G M; Kuiken Thijs; van Amerongen Geert; Osterhaus Albert D M E.In vitro and in vivo replication of seal gammaherpesviruses in cells of multiple species.Microbes and infection / Institut Pasteur 2007;9(1):40-6.
  17. Martina Byron E E; van Doornum Gerard; Dorrestein Gerry M; Niesters Hubert G M; Stittelaar Koert J; Wolters Marno A B I; van Bolhuis Hester G H; Osterhaus Albert D M E.Cowpox virus transmission from rats to monkeys, the Netherlands.Emerging infectious diseases 2006;12(6):1005-7.
  18. Martina B E E; Harder T C; Osterhaus A D M E.Purification of phocid herpesvirus type 1 glycoproteins B and D and pilot studies of immunogenicity in mice.Vaccine 2006;24(1):90-4.
  19. van den Brink Edward N; Ter Meulen Jan; Cox Freek; Jongeneelen Mandy A C; Thijsse Alexandra; Throsby Mark; Marissen Wilfred E; Rood Pauline M L; Bakker Alexander B H; Gelderblom Hans R; Martina Byron E; Osterhaus Albert D M E; Preiser Wolfgang; Doerr Hans Wilhelm; de Kruif John; Goudsmit Jaap.Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.Journal of virology 2005;79(3):1635-44.
  20. Philippa J D W; Leighton F A; Daoust P Y; Nielsen O; Pagliarulo M; Schwantje H; Shury T; Van Herwijnen R; Martina B E E; Kuiken T; Van de Bildt M W G; Osterhaus A D M E.Antibodies to selected pathogens in free-ranging terrestrial carnivores and marine mammals in Canada.The Veterinary record 2004;155(5):135-40.


Profile Details

NULL